IceCure Medical Ltd. ICCM
Medical/Dental Instruments · data as of November 13, 2026
IceCure Medical Ltd. (ICCM) is a healthcare company listed in the US with a market value of about $3M. In fiscal year 2025 it had revenue of $3M and net income of -$15M, a net margin of -445.6%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -3% a year, a 5-year average ROIC of -94%.
About IceCure Medical
IceCure Medical is listed in the US and classified in medical/dental instruments. Revenue went from $2M in 2019 to $3M in 2025, growth of about 13.0% a year. It was profitable in 0 of the last 7 years in our data. It spends 220% of revenue on research and development.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $3M | $4M | $4M | $2M |
| Net income | -$15M | -$15M | -$15M | -$17M | -$10M | -$4M | -$5M |
| Free cash flow | -$15M | -$13M | -$13M | -$15M | -$13M | -$4M | -$2M |
| EPS (diluted) | $-4.39 | $-4.47 | $-4.28 | $-4.96 | $-2.89 | $-1.09 | $-1.33 |
| Net margin | -445.6% | -465.4% | -453.8% | -550.3% | -239.1% | -96.4% | -279.7% |
| ROIC | -128.5% | -164.9% | -96.4% | -50.8% | -27.0% | -48.6% | -114.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does IceCure Medical pay a dividend?
Not currently.
Is IceCure Medical a good stock to buy?
We do not give buy or sell advice. IceCure Medical scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.